CompletedNot applicableNCT01557582
Assessmet of Patients With PAH Right Ventricular Volume
Studying Heritable pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- VentriPoint Diagnostics Ltd.
- Principal Investigator
- Robyn Barst, MDScientific Advisory Board
- Intervention
- Ventripoint Medical System(device)
- Enrollment
- 103 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2012 – 2013
Study locations (7)
- University of Chicago, Chicago, Illinois, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
- Baylor, Houston, Texas, United States
- Toronto General Hospital, Tononto, Ontario, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01557582 on ClinicalTrials.govOther trials for Heritable pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06850792imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNceUniversity of Sao Paulo General Hospital
- ACTIVE NOT RECRUITINGNCT06587074Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific TherapyRussian Cardiology Research and Production Center
- RECRUITINGNCT05462574Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)Vanderbilt University Medical Center
See all trials for Heritable pulmonary arterial hypertension →